BIAL enters the US and acquires “promising” Parkinson’s disease programmes

News

Author: Simge Eva DoganPublished: 8 October 2020

Prep: Cook: Serves:

BIAL Parkinson's research and development department

Portugal-based pharmaceutical company BIAL has launched a new research centre, BIAL Biotech, in Massachusetts, US, which will focus on genetically defined Parkinson’s disease.

BIAL has also announced that it has acquired the Parkinson’s disease research programmes of Lysosomal Therapeutics Inc, as well as its research and development team and clinical programme for LTI-291 – a therapy designed to treat a genetic form of the condition.

António Portela, executive president of BIAL, said: “Our entry into the US with the creation of BIAL Biotech and the acquisition of the promising programmes from LTI, is a decisive step towards the fulfilment of our mission to contribute to improving the quality of life of people worldwide.

“The development of this new research centre in the US, is a landmark of enormous relevance for us. We are investing in science and research, through our direct presence in one of the most important research hubs in the world and in one of the most promising areas of medicine.”

Lead image: research and development department at BIAL

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

I’ve got Parkinson’s and cancer: Billy Connolly’s tear-jerking appeal

Viewers praise “brilliant” Billy Connolly charity video

Watch: Judas Priest guitarist Glenn Tipton returns to stage after Parkinson’s diagnosis

The guitarist was back in action at a rock festival in Sweden

That moment the doc drops the P bomb

What it’s like to be diagnosed with Parkinson’s at 29 years old

Improving access to Parkinson’s disease resources on Amazon’s Alexa

US non-profit Parkinson’s Foundation has announced a new partnership with Amazon’s smart speaker Alexa to help more people access resources related to Parkinson’s disease. As part of the collaboration, Alexa-enabled devices will answer questions about Parkinson’s disease in English and Spanish, citing sources from the Parkinson’s Foundation. The educational initiative is aimed at people with the condition, their care partners, family and friends and health professionals – and will help them find information on topics including Covid-19 and Parkinson’s, symptoms and early signs of the condition, and more. John L Lehr, president and CEO of the Parkinson’s Foundation, said: “We are thrilled to work with Amazon to move into this exciting world of smart speakers to help even more people gain access to the information about Parkinson’s disease they need most. Our hope is that this partnership will help us further reach and better support the Parkinson’s disease community throughout every…

Scientists at MIT uncover new clues about Parkinson’s disease

Neuroscientists at Massachusetts Institute of Technology (MIT), US, have developed new tools that could improve understanding of Parkinson’s disease. As part of a study, published in Science Advances, the tools were used on animals to investigate the relationship between two types of signals that are disrupted in Parkinson’s – dopamine signalling and beta-band oscillations (coordinated waves of electrical activity in the brain). The scientists found that while the animals performed certain tasks, beta-band oscillations increased while dopamine signalling declined in particular parts of the brain. Factors including an animal’s past experience and the reward value of a task also impacted the relationship between the two signals. Helen Schwerdt, a research scientist at MIT, said: “Considering electrical signals side by side with chemical signals is really important to understand how the brain works.” Ann Graybiel, a professor at MIT, added: “As these methods in neuroscience become more and more precise and…

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

A new database study of around 80,000 Covid-19 patients has found that those living with Parkinson’s disease have a 30% higher risk of dying from the virus than those without the condition. The study – conducted by researchers at the University of Iowa Health Care, US – identified that Covid-19 patients with Parkinson’s disease were generally older, more likely to be male and less likely to be African American. As these factors could also affect the risk of death from Covid-19, the researchers adjusted their statistical models to account for differences in sex, age and race and found a significantly higher risk of dying from Covid-19 in the group of patients with Parkinson’s disease. Lead researcher Dr Nandakumar Narayanan said: “We recognise the limitations of this study; it is retrospective data from a single database, but we are confident that these data show that Parkinson’s disease is [an] independent risk factor…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

News

Author: Simge Eva DoganPublished: 8 October 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

I’ve got Parkinson’s and cancer: Billy Connolly’s tear-jerking appeal

Global update

Watch: Judas Priest guitarist Glenn Tipton returns to stage after Parkinson’s diagnosis

Perspectives

That moment the doc drops the P bomb

Improving access to Parkinson’s disease resources on Amazon’s Alexa

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

{title}

Subscribe

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

News

Author: Simge Eva DoganPublished: 8 October 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

I’ve got Parkinson’s and cancer: Billy Connolly’s tear-jerking appeal

Global update

Watch: Judas Priest guitarist Glenn Tipton returns to stage after Parkinson’s diagnosis

Perspectives

That moment the doc drops the P bomb

Improving access to Parkinson’s disease resources on Amazon’s Alexa

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

{title}

Subscribe

Sign in